Abstract:OBJECTIVE:To examine the effect of Bone Morphogenetic protein-7 (BMP-7) on Monocyte chemoattractant protein-1 (MCP-1) induced epithelial-myofibroblast transition (EMT) in cultured renal proximal tubular cells (HK-2) and the relationship between TGF-beta1-smad 3 expressions and MCP-1 induced EMT.METHODS:The cultured HK-2 cells were divided into six groups: a, negative control, b, treated with TGF-beta1 (5 ng/ml) as positive control, c, treated with MCP-1 (0.1, 1, 10, 50 ng/ml), d, treated with BMP-7 (0.1, 1, 10, 50 ng/ml), e. co-treated with MCP-1 (1 ng/ml) and MCP-1 neutralized antibody (1 ng/ml), f. co-treated with MCP-1 (1 ng/ml) and BMP-7 (50 ng/ml). alpha-Smooth Muscle Actin (alpha-SMA) mRNA expression of HK-2 cells was assessed with RT-PCR. Secretion of type I collagen was assessed with RT-PCR and ELISA, respectively. TGF-beta1 and Smad 3 expressions were assessed with Western blot.RESULTS:alpha-SMA mRNA expression significantly increased in HK-2 cells treated with MCP-1 (0.1, 1 ng/ml) compared with negative controls (5.97 +/- 0.35, 23.36 +/- 1.37 vs. 0.59 +/- 0.38, P < 0.01). alpha-SMA mRNA expression of HK-2 cells concomitantly treated with MCP-1 neutralized antibody or BMP-7 (50 ng/ml) and MCP-1 (1 ng/ml) significantly decreased than that in cells treated with MCP-1 (1 ng/ml) alone (1.93 +/- 0.34, 13.59 +/- 0.38 vs. 36.36 +/- 1.37, P < 0.01). Secretion of type I collagen of the cells treated with MCP-1 (0.1, 1 ng/ml) markedly increased compared with negative control (1751 +/- 34, 1876 +/- 45 vs. 1450 +/- 62; P < 0.01). The secretion of type I collagen of the supernatant were also significantly lower than that in cells treated with MCP-1 (1 ng/ml) alone (1462 +/- 56, 1596 +/- 34 vs. 1876 +/- 45, P < 0.05). The expression of TGF-beta1 and Smad 3 of HK-2 cells treated with MCP-1 (1 ng/ml) were markedly higher than that of negative controls, respectively (36.31 +/- 1.37 vs. 0.75 +/- 0.16, P < 0.01; 56.98 +/- 2.61 vs. 23.05 +/- 1.82, P < 0.01). The expressions of TGF-beta1 and Smad 3 in HK-2 cells treated concomitantly with MCP-1 neutralized antibody or BMP-7 (50 ng/ml) and MCP-1 (1 ng/ml) were markedly decreased than that treated with MCP-1 alone, respectively. (4.61 +/- 0.74, 23.74 +/- 2.14 vs. 36.31 +/- 1.37, P < 0.01; 19.63 +/- 1.65, 37.06 +/- 1.82 vs. 56.98 +/- 2.61, P < 0.01). The expressions of TGF-beta1 and Smad 3 in HK-2 cells treated concomitantly with MCP-1 neutralized antibody or BMP-7 (50 ng/ml) and MCP-1 (1 ng/ml) were markedly decreased than that treated with MCP-1 alone, respectively. (4.61 +/- 0.74, 23.74 +/- 2.14 vs. 36.31 +/- 1.37, P < 0.01; 19.63 +/- 1.65, 37.06 +/- 1.82 vs. 56.98 +/- 2.61, P < 0.01).CONCLUSIONS:The results documented that MCP-1 may induce EMT of HK-2 cells in vitro, and this effect is related to up-regulated expression of TGF-beta1 and Smad 3. BMP-7 may partially inhibit MCP-1-induced EMT and this effect is related to the downregulated expression of TGF-beta1 and Smad 3 of the cells. The results also suggest that MCP-1 induced EMT may involve the TGF-beta1-independent pathway of the cells.

[Transfection of Recombinant Bone Morphogenetic Protein-7 Expressing Plasmid into Cultured Human Renal Tubular Epithelial Cells Attenuates the Extracellular Matrix Accumulation Induced by Transforming Growth Factor-Beta].

Antagonistic Effect of Bone Morphogenetic Protein-7 on Transforming Growth Factor-Β1 Induced Extracellular Matrix Synthesis

Effect of BMP-7 on the transdifferentiation of cultured human tubular epithelial cell induced by TGF-beta1]

BMP7 antagonizes TGF-β-dependent fibrogenesis in mesangial cells

[Effects of Bone Morphogenic Proteins-7 on Production of Collagen from Hepatocytes and Hepatic Stellate Cells During Liver Fibrosis].

BMP-7 Counteracts TGF0-β1-induced Tubular Epithelial-Myofibroblast Transdifferentiation of Cultured Renal Tubular Epithelial Cells

The Anti-Fibrotic Effect Of Bone Morphogenic Protein-7(Bmp-7) On Liver Fibrosis

Overexpression of BMP-7 reverses TGF-1-induced epithelial-mesenchymal transition by attenuating the Wnt3/-catenin and TGF-1/Smad2/3 signaling pathways in HK-2 cells

[Effect of Bone Morphogenetic Protein-7 on Monocyte Chemoattractant Protein-1 Induced Epithelial-Myofibroblast Transition and TGF-beta1-Smad 3 Signaling Pathway of HKC Cells].

Inhibitory Effect of Bone Morphogenetic Protein-7 on Hepatic Fibrosis in Rats

BMP6 Reverses TGF-β1-induced Changes in HK-2 Cells: Implications for the Treatment of Renal Fibrosis

Bone Morphogenetic Protein-7 Promotes Chondrogenesis in Human Amniotic Epithelial Cells

Bone Morphogenic Protein-7 Inhibits Monocyte-Stimulated TGF- 1 Generation in Renal Proximal Tubular Epithelial Cells

The Attenuation Effect of Bone Morphogenetic Protein-7 on Liver Fibrosis in Rats

Smad7 Inhibits Fibrotic Effect of TGF- on Renal Tubular Epithelial Cells by Blocking Smad2 Activation

Effects of Transforming Growth Factor-β1 on Renal Extracellular Matrix Components and Their Regulating Proteins

[Connective Tissue Growth Factor Synergistically with Transforming Growth Factor Beta 1 to Promote Renal Fibrosis].

[Smad7 Instead of Smad6 Blocks Epithelial-Mesenchymal Transition Induced by TGF-beta in Human Renal Proximal Tubule Epithelial Cells].

Role of Connective Tissue Growth Factor in Extracellular Matrix Degradation in Renal Tubular Epithelial Cells

Role of Connective Tissue Growth Factor in Renal Tubular Epithelial-Myofibroblast Transdifferentiation and Extracellular Matrix Accumulation in Vitro.

Bone morphogenetic protein-3 is a negative regulator of transforming growth factor beta and fibrosis